Validity of the time trade-off and standard gamble methods of utility assessment in retinal patients - Wikidata - wikimedia - TriplyDB

Validity of the time trade-off and standard gamble methods of utility assessment in retinal patients

Validity of the time trade-off and standard gamble methods of utility assessment in retinal patients

http://www.wikidata.org/entity/Q35589718

about

Health State Utility Values for Age-Related Macular Degeneration: Review and Advice.Rhegmatogenous retinal detachment surgery in elderly people over 70 years old: visual acuity, quality of life, and cost-utility values.A comparison of the sensitivity of EQ-5D, SF-6D and TTO utility values to changes in vision and perceived visual function in patients with primary open-angle glaucoma.Health state utilities in patients with diabetic retinopathy, diabetic macular oedema and age-related macular degeneration: a systematic review.Utilities associated with diabetic retinopathy: results from a Canadian sample.Value-based medicine: evidence-based medicine and beyond.Validity of EuroQOL-5D, time trade-off, and standard gamble for age-related macular degeneration in the Singapore population Disparities between Ophthalmologists and Patients in Estimating Quality of Life Associated with Diabetic Retinopathy Quality of life and relative importance: a comparison of time trade-off and conjoint analysis methods in patients with age-related macular degeneration Impact of visual impairment on service and device use by individuals with diabetic retinopathy.Cost-Effectiveness Models in Age-Related Macular Degeneration: Issues and Challenges.Developing an algorithm to convert routine measures of vision into utility values for glaucoma.Cost-effectiveness of intravitreal aflibercept versus other treatments for wet age-related macular degeneration in Japan.Cost-utility analysis of screening for diabetic retinopathy in Japan: a probabilistic Markov modeling study.Value based medicine.The impact of persistent visually disabling vitreous floaters on health status utility values.Cost-utility analysis of cataract surgery in Japan: a probabilistic Markov modeling study.Cost-utility analysis of rhegmatogenous retinal detachment surgery in Shanghai, China.Risk perception of unruptured intracranial aneurysms.Assessing disutility associated with diabetic retinopathy, diabetic macular oedema and associated visual impairment using the Vision and Quality of Life Index.Cost-effectiveness of cataract surgery in Japan.Quality of life and cost-utility assessment after strabismus surgery in adults.A Value-Based Medicine cost-utility analysis of genetic testing for neovascular macular degeneration.Analysis of SNPs in pooled DNA: a decision theoretic model.The comparative effectiveness and cost-effectiveness of ranibizumab for neovascular macular degeneration revisited.Triple combination therapy and zeaxanthin for the treatment of neovascular age-related macular degeneration: an interventional comparative study and cost-effectiveness analysis.Ready-made and custom-made eyeglasses in India: a cost-effectiveness analysis of a randomised controlled trial

P2860

Q30393038-3E098FB8-8004-4349-B1C6-0764AD07C9CA Q34362086-4E953410-B60B-47C8-81DA-E42AFD1F520F Q34386849-FFB3440B-1F96-4EB8-AB95-FDACDFEDFD70 Q35059037-EFF5F6F1-6980-465B-ACA6-4A7FAC23BAE6 Q35070969-8548BB14-301B-4964-977C-70EA269A4714 Q35563038-025B9042-2393-4A2D-9F18-1CE20094818B Q35820332-C3D374C0-1BDC-48CB-A3FA-A20A3558BC7C Q35859211-709E959F-11EA-406C-9CD1-C53B933BF4BE Q35956212-B6DF7A3C-13BB-423A-8AE9-48BD840868E8 Q37353974-B8E9795A-E05E-48EB-8849-1FDEB70FF44A Q38631993-5AA96D70-F494-4B51-B8D2-F65EAB3CBBED Q38867249-AAA15146-5F82-4C63-82C3-06482122ED86 Q39323991-81FEE843-EF90-411F-9E83-E2466071D320 Q41678993-28CF8CC1-D0FB-4920-82D2-B0AE356B0625 Q43007186-CB7049EE-38F5-4B58-8782-39D62016FBF6 Q44829814-16EDC7BE-62B3-475B-8E13-E85FC94243C1 Q45908117-F336878B-9677-431C-A2C6-9E6B7A8D924F Q48085792-606A887D-8CD0-4958-B8A9-10F0D8E65443 Q48191995-4B2F3C57-A248-4087-B0C9-225F9053C617 Q48450020-C6EFF34C-E1B0-4488-BA85-A178128AF990 Q48643706-96F66ABC-9F27-4977-A8AD-E494D43B0D0F Q48684165-2472D0B0-DCEB-4C45-98FC-097E00639530 Q51324823-44F14D55-6CB2-4F8F-B30F-50EA8D43548B Q52005896-C5B739F2-4857-4767-9A2A-8E622DE3A267 Q53438701-93E11A2A-02A4-4AF8-B36B-4FC698CDA4EA Q54571267-FA15B92F-78F5-4EC3-AC42-30C1E2E6CD49 Q58185179-4B44CB62-9461-4228-8ED9-5A3579B41468

P2860

Validity of the time trade-off and standard gamble methods of utility assessment in retinal patients

http://www.wikidata.org/entity/Q35589718

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

2002年论文

@zh

2002年论文

@zh-cn

name

Validity of the time trade-off ...... assessment in retinal patients

@ast

Validity of the time trade-off ...... assessment in retinal patients

@en

type

label

Validity of the time trade-off ...... assessment in retinal patients

@ast

Validity of the time trade-off ...... assessment in retinal patients

@en

prefLabel

Validity of the time trade-off ...... assessment in retinal patients

@ast

Validity of the time trade-off ...... assessment in retinal patients

@en

P1433

Q35589718-88BA6AC0-3EC0-4017-B539-8D3BDBD63306

P1476

Q35589718-7A538CEE-FC9C-4A33-8AD9-774CE7F729C3

P2093

Q35589718-0A0BF571-B8C9-4917-B94C-B69AECAD45F1

Q35589718-1D861786-C495-4BA7-A0F6-27782DA7F264

Q35589718-78B330C6-BECE-4B34-91C5-840B5A033984

Q35589718-A22ABCB4-3D56-4EE5-9156-05D1F70EB5C8

Q35589718-A3346BCC-FBD9-41A1-8AE4-691878F0D754

Q35589718-F25CAC71-BC73-4220-9A3A-9D565D49D58A

P2860

Q35589718-08B2076E-EDAB-4AE3-8026-8B19FE48C694

Q35589718-0CB53F77-5005-40D9-9754-0C5644EFAF49

Q35589718-6DAEF187-1055-4767-8D61-D8FA89425EF7

Q35589718-72B985AF-838B-40A8-8027-2100C27949A3

Q35589718-9AAB62E0-DD56-4469-B345-2C20D1DA8AB7

Q35589718-B75C0068-E652-4FE7-897E-07A7E6BCF2C6

Q35589718-B7E4AA0A-B5A3-4D8F-A5E0-4664385AB240

Q35589718-D846FE3A-2C57-4A0C-920B-5EB148BB10C9

Q35589718-D957AA9A-301C-418F-B45F-86475D91541F

Q35589718-D9989F29-2311-45B6-9BF3-FEABEA7BADDD

P304

Q35589718-0262B0B9-F7C5-43B9-9454-816D3BB23F2E

P31

Q35589718-7729C96D-A6E8-439E-947A-60197FBA8397

P356

Q35589718-907AAF22-4BBE-4132-BE62-84E0A7BBB986

P407

Q35589718-C59170E5-B1C1-4955-988B-85EDC1AEC37A

P433

Q35589718-AFA4DBD2-A341-4B75-97AA-F1D52AA657E8

P478

Q35589718-B27083B1-AC1D-4657-B870-1D25D4AC0844

P577

Q35589718-50D10235-5D7A-41D1-A60A-2E97D2427859

P698

Q35589718-61DBEB68-2432-4B3D-A15F-C431B3C10149

P932

Q35589718-2C52DCD5-C097-4465-B333-9998F5D26F63

P356

P1433

British Journal of Ophthalmology

P1476

Validity of the time trade-off ...... assessment in retinal patients

@en

P2093

Brown GC

http://www.w3.org/2001/XMLSchema#string

Brown MM

http://www.w3.org/2001/XMLSchema#string

Hollands H

http://www.w3.org/2001/XMLSchema#string

Robins R

http://www.w3.org/2001/XMLSchema#string

Shah GK

http://www.w3.org/2001/XMLSchema#string

Sharma S

http://www.w3.org/2001/XMLSchema#string

P2860

A utility maximization model for evaluation of health care programs

Cost-effectiveness of treatment for threshold retinopathy of prematurity.

Incremental cost effectiveness of laser photocoagulation for subfoveal choroidal neovascularization.

Incremental cost-effectiveness of laser therapy for choroidal neovascularization associated with histoplasmosis.

The cost-effectiveness of grid laser photocoagulation for the treatment of diabetic macular edema: results of a patient-based cost-utility analysis.

Converting visual acuity to utilities.

Measuring health-related quality of life.

A taxonomy of health status instruments.

Identifying the content area for the 51-item National Eye Institute Visual Function Questionnaire: results from focus groups with visually impaired persons.

Utility values and age-related macular degeneration.

P304

493-496

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BJO.86.5.493

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

86

http://www.w3.org/2001/XMLSchema#string

P577

2002-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11973240

http://www.w3.org/2001/XMLSchema#string

P932

1771136

http://www.w3.org/2001/XMLSchema#string